
Loading, please wait...

Loading, please wait...

Effective management of diabetes relies heavily on continuous glucose monitoring. However, traditional invasive testing methods often carry risks of injury and discomfort for patients. Consequently, researchers are prioritizing the development of noninvasive sweat glucose monitoring technology. A recent study has successfully introduced a stretchable organic field-effect transistors (OFETs) biosensor designed for this purpose.
This innovative sensor utilizes chemically cross-linked glucose oxidase to optimize the functionalization interface. Specifically, the researchers used Density Functional Theory (DFT) calculations and atomic force microscopy (AFM) to refine the sensing mechanism. This process ensures the device maintains high selectivity while using only 1 mL of analyte. Therefore, it represents a significant leap in wearable diagnostic capabilities.
The newly developed biosensor operates at a remarkably low working voltage of less than 5 V. Furthermore, it demonstrates an impressive detection limit as low as 0.01 μM and a sensitivity of 152 μA/mM/cm². This high level of precision allows for the detection of minute glucose concentrations in sweat, which correlates with systemic levels. Additionally, the sensor exhibits excellent mechanical strain adaptability, showing minimal signal fluctuation under physical stress.
Moreover, the integration of these stretchable OFETs into wearable formats could revolutionize chronic disease management in India. Since India has a high prevalence of diabetes, such noninvasive tools may improve patient compliance and long-term health outcomes. These sensors provide a painless alternative to daily finger-pricks, making continuous monitoring more accessible for everyone.
While blood glucose remains the gold standard, sweat glucose levels show a strong correlation with blood levels. Advanced biosensors are designed to account for the time lag and concentration differences to provide reliable data.
The OFETs biosensor is designed with mechanical strain adaptability. This means it can withstand the regular stretching and movement of human skin without losing its sensing accuracy.
This sensor stands out due to its extremely low detection limit (0.01 μM) and low operating voltage. These features ensure it is both highly sensitive and energy-efficient for long-term wearable use.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional relationship between the reader and the author. While we strive for accuracy, the rapidly evolving nature of medical research means new data may emerge. Refer to the latest local and national guidelines for clinical practice.
References
Bi J et al. Stretchable OFETs Biosensors Based on Chemically Cross-Linked Glucose Oxidase for Noninvasive Sweat Glucose Detection. Anal Chem. 2026 Feb 13. doi: 10.1021/acs.analchem.5c05787. PMID: 41685563.
Bresci A et al. Noninvasive imaging could replace finger pricks for people with diabetes. MIT News. December 2025.
Diabetotech. Non-Invasive CGMs: Are We There Yet? November 2025.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Researchers have developed a stretchable OFETs biosensor for high-sensitivity, noninvasive sweat glucose monitoring, revolutionizing diabetes management....
5 months ago

A Bayesian network meta-analysis evaluated non-surgical treatments for benign thyroid nodules, finding thermal ablation techniques like laser and radiofrequency ablation superior in nodule volume reduction, whereas levothyroxine showed the strongest TSH suppression without significant changes in FT3 or FT4.
Today

A retrospective study demonstrates that deep learning models using longitudinal digital breast tomosynthesis significantly enhance 5-year breast cancer risk prediction compared to single-timepoint imaging and clinical models.
Today

Researchers developed poly(trimethylene carbonate)-based polymersomes loaded with L-arginine for ROS-triggered nitric oxide release. This mild, stable nano-delivery system produces gas in response to hydrogen peroxide, offering a promising, targeted platform for cardiovascular, surgical, and oncological therapy.
Today

Researchers developed a Haversian-inspired composite scaffold that addresses delayed vascularization and wet-state mechanical deterioration in critical bone defect repair. By integrating spatially programmed calcium phosphate minerals and selective silica reinforcement, the design promotes vascularized bone repair.
Yesterday

A landmark study analyzing over 56,000 adult health records in Delhi-NCR reveals that hypertension and diabetes coexistence affects nearly 5% of adults. The prevalence doubles expected rates and rises sharply after age 40. Early integrated screening is essential to prevent microvascular and macrovascular complications.
Today